Baseline Results of the West London lung cancer screening pilot study – Impact of mobile scanners and dual risk model utilisation

The recent publication of the Dutch-Belgian lung-cancer screening trial (Nederlands –Leuvens Longkanker Screenings Onderzoek [NELSON]) [1] corroborates the findings of the earlier United States National Lung Screening Trial (NLST) [2] in confirming the benefits of low-dose CT (LDCT) screening for reducing lung cancer mortality. De Koning et al. report a reduction in lung cancer m ortality of 24 % in males, and 33 % in females at 10 years, achieved through interval LDCT screening compared to a control group [1].

Source: Lung Cancer - July 30, 2020 Category: Cancer & Oncology Authors: Emily C. Bartlett, Samuel V. Kemp, Carole A. Ridge, Sujal R. Desai, Saeed Mirsadraee, Jaymin B. Morjaria, Pallav L. Shah, Sanjay Popat, Andrew G. Nicholson, Alexandra J. Rice, Simon Jordan, Sofina Begum, Aleksander Mani, Jane Derbyshire, Katie Morris, Mic Source Type: research